<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01769794</url>
  </required_header>
  <id_info>
    <org_study_id>ChinaACMS-HFMD</org_study_id>
    <nct_id>NCT01769794</nct_id>
  </id_info>
  <brief_title>Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chengdu University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin infectious disease hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tangshan infectious disease hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tianjin Zhongshenghaitian Pharmaceutical Co. Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>China Academy of Chinese Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is aimed to evaluate the effectiveness and safety of Jinlianqingre Effervescent
      Tablets, a traditional Chinese medicine (TCM), in the treatment of Uncomplicated hand, foot,
      and mouth disease (HFMD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      By adopting a multicenter, prospective, randomized double-blind, placebo-controlled, this
      study is aimed to evaluate the effectiveness, safety of a traditional Chinese medicine,
      Jinlianqingre Effervescent Tablets, for treatment Uncomplicated HFMD, and to provide
      scientific evidence for the construction of TCM methods in treating HFMD.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The time of body temperature going back to normal</measure>
    <time_frame>10 days</time_frame>
    <description>Referring to the time of the armpit temperature of lower than 37.0 degrees Celsius, lasting for at least 24 hours, after the medicine is taken.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Healing time of skin or oral mucosa lesions symptom</measure>
    <time_frame>10 days</time_frame>
    <description>Referring to the number of days in the total-contact cast until the skin completely closed after the medicine is used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Score of skin or oral mucosa lesions symptom during the study period time</measure>
    <time_frame>10 days</time_frame>
    <description>Referring to Symptoms were hands, feet, oral mucosa lesions, buttock, crissum, back and four limbs. Each symptom was scored as 0 (none), 1 (mild), 2 (modest), or 3 (severe).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the length of hospital stay</measure>
    <time_frame>10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>major complications rate</measure>
    <time_frame>10 days</time_frame>
    <description>Referring to pulmonary edema, cardiac damage, pneumonia, secondary infection, meningitis, encephalomyelitis et al.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">288</enrollment>
  <condition>Hand, Foot and Mouth Disease</condition>
  <arm_group>
    <arm_group_label>Western therapy &amp; Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Western therapy(oral care, skin care and reducing temperature) Placebo for JET(Jinlianqingre Effervescent Tablets )</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Western therapy &amp; JET</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Jinlianqingre Effervescent Tablets plus western therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Western therapy</intervention_name>
    <description>Physical cooling paste or warm bathing, vitamin B, vitamin C. On the basis of the attending physician's judgment, participants were allowed to use Ibuprofen suspension if their body temperature was greater than 38.5℃. Likewise, the need for antibiotics was determined by the attending physicians. The use of acetaminophen or antibiotics was recorded on the case record form</description>
    <arm_group_label>Western therapy &amp; Placebo</arm_group_label>
    <arm_group_label>Western therapy &amp; JET</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>JET</intervention_name>
    <description>4g/tablet, One tablet each time (Taken after dissolved in 50ml boiled water, 3 times daily if body temperature≥38.5℃)</description>
    <arm_group_label>Western therapy &amp; JET</arm_group_label>
    <other_name>Jinlianqingre Effervescent Tablets</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo(for JET)</intervention_name>
    <description>placebos prepared identical in color, taste and consistency to the JET (supplied by Zhongshenghaitian Pharmaceutical, Tianjin, China)</description>
    <arm_group_label>Western therapy &amp; Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of mild hand-foot-mouth disease patients according to
             Hand-Foot-Mouth Disease Treatment Guidelines 2010 issued by China's Ministry of
             Health;

          -  Within 48 hours of onset of fever and rash symptom.

          -  Age of 1-13 years.

          -  Documented body temperature 37.4 °C-39.0°C

          -  Patients or their guardians agree to participate in this study and signed the informed
             consent form.

        Exclusion Criteria:

          -  Complicated with other serious diseases such as chronic hepatitis,chronic diarrhea
             disease,chronic diarrhea, congenital heart disease, acute or chronic nephritis and
             blood diseases.

          -  With history of allergies on traditional Chinese medicine.

          -  Attending other clinical studies on HFMD after diagnosed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boyan Liu, chief physician</last_name>
    <role>Study Chair</role>
    <affiliation>China Academy of Chinese Medical Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Guoliang Zhang, chief</last_name>
    <role>Study Chair</role>
    <affiliation>The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tangshan infectious disease hospital</name>
      <address>
        <city>Tangshan</city>
        <state>Hebei</state>
        <zip>063020</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Chengdu university of Traditional Chinese Medicine</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610072</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing children's hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100045</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tianjin infectious disease hospital</name>
      <address>
        <city>Tianjin</city>
        <zip>300192</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2013</study_first_submitted>
  <study_first_submitted_qc>January 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2013</study_first_posted>
  <last_update_submitted>January 16, 2013</last_update_submitted>
  <last_update_submitted_qc>January 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Academy of Chinese Medical Sciences</investigator_affiliation>
    <investigator_full_name>Liyun He</investigator_full_name>
    <investigator_title>chief</investigator_title>
  </responsible_party>
  <keyword>Hand, Foot and Mouth Disease</keyword>
  <keyword>Medicine, Chinese Traditional</keyword>
  <keyword>Enterovirus</keyword>
  <keyword>Fever</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mouth Diseases</mesh_term>
    <mesh_term>Foot-and-Mouth Disease</mesh_term>
    <mesh_term>Hand, Foot and Mouth Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

